Dr Fawad Ur Rehman holds a PhD in Biomedical Engineering from the Southeast University, Nanjing, China and specialises in nanomedicine and nano-drug delivery systems.  His research interest lies in developing Blood-Brain Barrier amenable nanoscale materials-based targeted therapies for brain diseases such as glioblastoma multiforme. At AKU-CRM he is currently leveraging his efforts to harness the potential of lipid nanoparticles and extracellular vesicles for the safe and efficacious delivery of gene editing tools. Before joining CRM, he was a group lead and senior postdoctoral fellow at Henan-MQ International Joint Center for Biomedical Innovation, Henan University, China. He was also a postdoctoral researcher at ZhongDa Hospital, affiliated with the Medical School of Southeast University, Nanjing, China. ​